Literature DB >> 16358363

PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis.

Spencer C Liang1, Rebecca J Greenwald, Yvette E Latchman, Lucia Rosas, Abhay Satoskar, Gordon J Freeman, Arlene H Sharpe.   

Abstract

To compare the roles of programmed death 1 ligand 1 (PD-L1) and PD-L2 in regulating immunity to infection, we investigated responses of mice lacking PD-L1 or PD-L2 to infection with Leishmania mexicana. PD-L1(-/-) and PD-L2(-/-) mice exhibited distinct disease outcomes following infection with L. mexicana. In comparison to susceptible WT mice, PD-L1(-/-) mice showed resistance to L. mexicana, as demonstrated by reduced growth of cutaneous lesions and parasite burden. In contrast, PD-L2(-/-) mice developed exacerbated disease with increased parasite burden. Host resistance to L. mexicana is partly associated with the development of a Th1 response and down-regulation of the Th2 response. Both PD-L1(-/-) and PD-L2(-/-) mice produced levels of IFN-gamma similar to WT mice. However, the development of IL-4-producing cells was reduced in PD-L1(-/-) mice, demonstrating a role for PD-L1 in regulating Th cell differentiation. This inadequate Th2 response may explain the increased resistance of PD-L1(-/-) mice. Although no alterations in Th1/Th2 skewing were observed in PD-L2(-/-) mice, PD-L2(-/-) mice exhibited a marked increase in L. mexicana-specific antibody production. Increased Leishmania-specific IgG production may suppress the healing response through FcgammaR ligation on macrophages. Taken together, our results demonstrate that PD-L1 and PD-L2 have distinct roles in regulating the immune response to L. mexicana.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16358363     DOI: 10.1002/eji.200535458

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  45 in total

Review 1.  PD-1, gender, and autoimmunity.

Authors:  Ravi K Dinesh; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-28       Impact factor: 9.754

2.  PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.

Authors:  Marguerite Ghiotto; Laurent Gauthier; Nacer Serriari; Sonia Pastor; Alemseged Truneh; Jacques A Nunès; Daniel Olive
Journal:  Int Immunol       Date:  2010-06-29       Impact factor: 4.823

Review 3.  Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Authors:  A K Singh; P Stock; O Akbari
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

4.  Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10.

Authors:  Marta Rodríguez-García; Filippos Porichis; Olivier G de Jong; Karen Levi; Thomas J Diefenbach; Jeffrey D Lifson; Gordon J Freeman; Bruce D Walker; Daniel E Kaufmann; Daniel G Kavanagh
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

5.  Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma.

Authors:  Jaclyn W McAlees; Stephane Lajoie; Krista Dienger; Alyssa A Sproles; Phoebe K Richgels; Yanfen Yang; Marat Khodoun; Miyuki Azuma; Hideo Yagita; Patricia C Fulkerson; Marsha Wills-Karp; Ian P Lewkowich
Journal:  Eur J Immunol       Date:  2015-02-26       Impact factor: 5.532

6.  Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Authors:  Dalia E Gaddis; Craig L Maynard; Casey T Weaver; Suzanne M Michalek; Jannet Katz
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

7.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

Review 8.  The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.

Authors:  Kathleen M Mahoney; Gordon J Freeman; David F McDermott
Journal:  Clin Ther       Date:  2015-03-29       Impact factor: 3.393

9.  Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.

Authors:  Xue Pan; Anyuan Zhong; Yufei Xing; Minhua Shi; Bin Qian; Tong Zhou; Yongjing Chen; Xueguang Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

10.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.